Hims & Hers Health Reports Mixed Q4 Earnings, Subscribers Cross 2.5 Million

Core Viewpoint - Hims & Hers Health reported mixed financial results for the fourth quarter, beating earnings per share estimates but missing revenue expectations, leading to stock volatility. Financial Performance - Fourth-quarter revenue was $617.82 million, missing analyst estimates of $619.22 million [1] - The company reported earnings of eight cents per share, exceeding estimates of three cents per share [1] - Total revenue increased by 28% year-over-year, with subscribers growing to over 2.5 million, a 13% increase from 2025 [2] - Gross margin for the fourth quarter was 72%, down from 77% in the same quarter of 2024 [2] - Operating cash flow was $61.3 million, while free cash flow was negative at $2.6 million [3] - The company ended the quarter with $228.62 million in cash and cash equivalents [3] Future Guidance - Hims & Hers expects first-quarter revenue between $600 million and $625 million, below estimates of $653.12 million [4] - Full-year 2026 revenue guidance is set at $2.7 billion to $2.9 billion, compared to estimates of $2.74 billion [4] Strategic Outlook - The company aims for at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030, supported by a strong balance sheet and operating cash flow [5] - Plans include investing in scaling new specialties, advancing technology and infrastructure, and expanding internationally [5] Stock Performance - Hims & Hers shares initially traded lower after the earnings report, showing volatility in after-hours trading, down 0.64% at $15.41 [7]